By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD186 - The Opioid Crisis with Patrick Radden Keefe
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Patrick Radden Keefe Unpacks Purdue, the Sacklers, and OxyContin's Rise
- Keefe traces the Sackler brothers' path from Brooklyn immigrant families to psychiatry, pharmaceutical advertising, and ownership of Purdue, and argues that Arthur Sackler's marketing of Librium and Valium foreshadowed the later OxyContin strategy.
- Purdue moved from MS Contin to OxyContin partly to extend patent life and expand into a much larger market of moderate and chronic pain, with internal emails showing executives choosing not to correct doctors' belief that oxycodone was weaker than morphine.
- Keefe describes a web of soft corruption involving FDA reviewer Curtis Wright, a DEA official turned lobbyist, medical associations funded by industry, politicians, and high-profile lawyers, which helped the drug win approval, spread, and escape consequences.
- Peter Attia shares his own experience of escalating to nearly 400 mg of OxyContin a day after a surgical error and back injury, illustrating how quickly dependence developed and how little pain-management training physicians received.
- The two discuss the weak outcome of the legal reckoning, including the 2007 plea, the roughly $10 billion siphoned out by the family, and the $4.5 billion bankruptcy settlement with third-party releases, and Keefe highlights the Sacklers' apparent detachment from reality and the difficult path forward on the ongoing crisis.
IDEAS WORTH REMEMBERING
5 ideasPatent life drove many of Purdue's strangest decisions.
Keefe says mysteries about the company's motivations kept turning out to involve patents, from the search for a MS Contin successor to the pediatric indication and the 2010 reformulation.
OxyContin was marketed to a far larger population than cancer patients.
Emails show executives wanted the market of moderate and chronic pain and chose not to correct doctors' mistaken belief that oxycodone was weaker than morphine.
The claim that the Contin seal reduced abuse liability had no scientific basis.
Keefe says there was no study behind the "is believed" line in the package insert, and that neither Curtis Wright nor Purdue officials will admit writing it.
Purdue knew about problems well before 2000.
Keefe says emails and sales rep reports show senior executives, including Paul Goldenheim, knew of abuse and overdoses by 1997 or earlier, contradicting their sworn claims of ignorance.
Corruption here was largely soft and structural rather than explicit bribery.
Keefe describes revolving doors, industry-funded education, and well-chosen messengers and lobbyists, noting that senators were influenced for hundreds of thousands of dollars and that the opioid industry outspent the gun lobby.
WORDS WORTH SAVING
5 quotesIt can be possible to stipulate that today the opioid crisis is a heroin and fentanyl crisis, and also to keep in your mind the idea that absent OxyContin, we might not be where we are today.
— Patrick Radden Keefe
On the other hand, there is a sense in which even as they were decrying the black market, like the black market was helping to pay the bills at the company.
— Patrick Radden Keefe
I also think there's what I would call a kind of soft corruption that pervades this whole process, and I don't think it's unique to Curtis Wright.
— Patrick Radden Keefe
I'm not lucky because I have willpower. I'm lucky because that chemical didn't put a hook in me the way it would in others.
— Peter Attia
You have a generation of doctors who learn how to like on-ramp their patients with these drugs and never learn how to off-ramp them.
— Patrick Radden Keefe
High quality AI-generated summary created from speaker-labeled transcript.
